Scientific Program

Conference Series Ltd invites all the participants across the globe to attend 22nd International Conference on Medicinal Chemistry, Drug Discovery & Drug Delivery London, UK.

Day 1 :

  • Drug Chemistry
Location: Montreal, Canada

Session Introduction

Bashar Mudhaffar Abdullah

Clinical Laboratory Technology Department, Al-Rafidain University College, Baghdad, Iraq

Title: Fatty Acids Composition, Triacylglycerol Profiles and Spectroscopy Study of Pure Olive Oil
Biography:

Bashar Mudhaffar Abdullah has completed his PhD at the age of 33 years from Universiti Kebangsaan Malaysia and postdoctoral studies also from Universiti Kebangsaan Malaysia. He has published more than 50 papers in reputed journals and attende more than 25 conferences.

Abstract:

This study was carried out to determine the fatty acids (FAs) composition, triacylglycerol profiles (TAG) and spectroscopy study of pure olive oil. Gas chromatography (GC) was used to determine the FAs of pure olive oil which is consisting of three major long chain FAs were detected in the pure olive oil, which is oleic 52.82%, linoleic 28.55% and palmitic 11.12% acids. Other FA composition was less than 10% and comprised of stearic 4.72% acid. High performance liquid chromatography (HPLC) was used to determine the TAG. The major TAG peaks in the study of pure olive oil were the OLL with 17.39%, OLO 23.14% and PLO with 10.92%. The FTIR spectroscopy showed the (C=C) at 3470cm-1. The results of this study showed that the pure olive oil is plausible source of polyunsaturated fatty acids (PUFAs) to be developed in the future for industrial applications.

 

  • Potential Inhibitors
Location: Montreal, Canada

Session Introduction

Miroslava Ndyalkova

Sofia University Chemistry and Pharmacy Faculty, Sofia 1172, Bulgaria

Title: Natural Products as Potential Inhibitors Against SARS‑CoV‑2 - Molecular docking and chemomoetrics study
Biography:

Miroslava Ndyalkova,Sofia University Chemistry and Pharmacy Faculty,  Sofia  1172, Bulgaria.

Abstract:

The emergence and rapid worldwide spread of the novel coronavirus disease, COVID-19, has prompted concerted efforts to find successful treatments. The causative virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – a strain of severe acute respiratory syndrome-related coronavirus. The discovery of new drugs that could target this complex efficiently would be a very long, multi-step and expensive process as every other drug discovery.

We propose a workflow of combined molecular docking study with cheminformatics methods classification methods that will be used to predict and identify novel drug by screening from the available data for the nature compound based on as well as for the essential oils interacting with Receptor Binding Domain (RBD).